If a patient is taking 100 mg of atenolol, what dose of carvedilol (Coreg) should she be switched to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Beta-Blocker Conversion: Atenolol to Carvedilol

When switching from atenolol 100 mg daily to carvedilol, start with carvedilol 6.25 mg twice daily (12.5 mg total daily dose) and titrate upward every 1-2 weeks as tolerated.

Rationale for Starting Dose

There is no direct 1:1 dose equivalency between atenolol and carvedilol because they have fundamentally different pharmacologic properties. Atenolol is a selective β1-blocker, while carvedilol is a nonselective β-blocker with additional α1-blocking (vasodilating) properties 1. This means carvedilol has more pronounced effects on blood pressure through vasodilation beyond simple β-blockade.

Titration Protocol

Start low and go slow:

  • Initial dose: Carvedilol 6.25 mg twice daily (or 3.125 mg twice daily if the patient has heart failure, recent MI, or hemodynamic concerns) 1
  • Titration schedule: Increase dose every 1-2 weeks based on tolerance 2, 3
  • Progression: 6.25 mg BID → 12.5 mg BID → 25 mg BID
  • Maximum dose: 25 mg twice daily for most indications (50 mg twice daily for heart failure patients >85 kg) 1

The FDA label explicitly states that carvedilol dosing "must be individualized and closely monitored during up-titration" 1. The starting dose of 6.25 mg twice daily applies to hypertension, while heart failure requires starting at 3.125 mg twice daily 1.

Clinical Context Matters

For hypertension: The standard conversion starts at carvedilol 6.25 mg twice daily, maintained for 7-14 days, then increased to 12.5 mg twice daily if needed 1. Guidelines confirm this approach, with carvedilol typically dosed at 6.25-25 mg twice daily for cardiovascular indications 4, 5, 6.

For heart failure: If this patient has heart failure with reduced ejection fraction (HFrEF), start even lower at 3.125 mg twice daily for 2 weeks, then titrate to 6.25 mg, 12.5 mg, and 25 mg twice daily over successive 2-week intervals 2, 3, 1.

For post-MI with LV dysfunction: Start at 6.25 mg twice daily (or 3.125 mg if hemodynamically unstable), increase after 3-10 days to 12.5 mg twice daily, then to target of 25 mg twice daily 1.

Monitoring During Conversion

Watch closely for:

  • Hypotension: Carvedilol's α1-blockade causes more vasodilation than atenolol. Monitor standing blood pressure 1 hour post-dose 1
  • Bradycardia: Reduce dose if heart rate drops below 55 bpm 1
  • Fluid retention: Particularly in heart failure patients; may need diuretic adjustment 1
  • Dizziness/lightheadedness: Common during initiation and dose increases, especially in the first hour after dosing 1

Key Differences Between These Agents

Research demonstrates that carvedilol provides superior outcomes compared to atenolol in several contexts:

  • Better pulse pressure amplification and reduced aortic wave reflection 7
  • Improved renal perfusion in cirrhosis patients 8
  • Superior cardioprotection in cardiorenal syndrome 9
  • Better long-term outcomes post-MI 10

However, atenolol may provide slightly longer duration of blood pressure control at equivalent β-blocking doses 11.

Common Pitfall to Avoid

Do not attempt a direct dose conversion. The 100 mg of atenolol does not translate to any specific "equivalent" dose of carvedilol. Always start with the recommended initial dose for carvedilol based on the indication, regardless of the previous atenolol dose. The vasodilating properties of carvedilol mean that starting too high risks significant hypotension 1.

Take carvedilol with food to slow absorption and reduce orthostatic effects 1.

References

Research

Carvedilol and atenolol once daily in the treatment of hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.